Navigation Links
Omeros Reports Positive Results from OMS824 Positron Emission Tomography Clinical Trial
Date:5/31/2013

ally lower PDE10 occupancy levels than that observed with OMS824. In contrast, these adverse side effects have not been seen at any of the OMS824 dose levels studied to date. This difference suggests that OMS824 has a better clinical therapeutic index or "safety factor" than other PDE10 inhibitors in development. Omeros plans to measure OMS824's binding to PDE10 in additional dose cohorts.

"These data underscore the unique pharmacology of Omeros' PDE10 inhibitor, OMS824," stated Gregory A. Demopulos , M.D., chairman and chief executive officer of Omeros. "To our knowledge, this is the first time that a PDE10 inhibitor has demonstrated this level of enzyme occupancy without associated extrapyramidal symptoms, a side effect commonly seen with antipsychotic drugs.  These results could translate into a significant competitive advantage across a wide range of CNS indications."  

About Omeros' PDE10 Program
PDE10 is an enzyme that is expressed in areas of the brain linked to diseases that affect cognition and psychomotor functions, including Huntington's disease and schizophrenia. Huntington's disease is a hereditary neurodegenerative disorder that leads to movement, cognition, and behavioral abnormalities and premature death. Cognitive dysfunction is responsible for substantial disability in these diseases and is not improved by current medications. Omeros' proprietary compound OMS824 inhibits PDE10 and is being developed for the treatment of cognitive disorders. In addition to potential benefits on cognition, OMS824 could also improve psychiatric manifestations, such as the positive (e.g., hallucinations) and negative (e.g., flat affect) symptoms of schizophrenia.

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Omeros to Present at Deutsche Bank Securities Health Care Conference
2. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
3. Omeros to Present at Jefferies 2012 Global Healthcare Conference
4. Omeros Announces Proposed Public Offering of Common Stock
5. Omeros Prices $30 Million Public Offering of Common Stock
6. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Omeros Announces Discovery in MASP-2 Program
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
11. Omeros to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015  BD (Becton, Dickinson and Company) (NYSE: ... company, today announced its participation in the White ... steps the company will take to help combat ... full range of expertise related to identification and ... information to electronic surveillance and prevention of health ...
(Date:6/2/2015)... N.Y. , June 2, 2015 ... its first television and multi-media commercial advertisement, which ... campaign to promote SNORenz®, the company,s top selling ... of the company,s past success with television advertising. ... advertisement, but this, more modern version takes an ...
(Date:6/2/2015)... e MADRID , June ... (abstract 10503) al meeting annuale della American Society of ... dati dello studio multicentrico di fase 3 SAR3007, resi ... , LLC (Janssen), hanno evidenziato un significativo miglioramento della ... trabectedina (YONDELIS ® ) rispetto al trattamento con dacarbazina ...
Breaking Medicine Technology:BD Participates in White House Forum on Antibiotic Stewardship 2BD Participates in White House Forum on Antibiotic Stewardship 3Northstar releases its direct response multi-media ad designed to be used in national television advertising campaigns 2PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 2PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 3PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 4PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 5PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 6
... Item Q3 2009 ... $80.8 ... $78.4 16% increase, Naglazyme ... 26% increase, Aldurazyme BioMarin, Net Product Revenue $14.6 ...
... WAYNE, Pa., Oct. 28 Qualsec (OTC Bulletin Board: QLSZ), ... Seelig, MD has been elected as a member of the ... 25 years of clinical experience followed by 6 years of ... the first and only FDA cleared RFID medical information device ...
Cached Medicine Technology:BioMarin Announces Third Quarter 2009 Financial Results 2BioMarin Announces Third Quarter 2009 Financial Results 3BioMarin Announces Third Quarter 2009 Financial Results 4BioMarin Announces Third Quarter 2009 Financial Results 5BioMarin Announces Third Quarter 2009 Financial Results 6BioMarin Announces Third Quarter 2009 Financial Results 7BioMarin Announces Third Quarter 2009 Financial Results 8BioMarin Announces Third Quarter 2009 Financial Results 9BioMarin Announces Third Quarter 2009 Financial Results 10BioMarin Announces Third Quarter 2009 Financial Results 11BioMarin Announces Third Quarter 2009 Financial Results 12BioMarin Announces Third Quarter 2009 Financial Results 13BioMarin Announces Third Quarter 2009 Financial Results 14BioMarin Announces Third Quarter 2009 Financial Results 15BioMarin Announces Third Quarter 2009 Financial Results 16BioMarin Announces Third Quarter 2009 Financial Results 17BioMarin Announces Third Quarter 2009 Financial Results 18VitaminSpice Appoints Dr. Richard F. Seelig as Director 2
(Date:6/2/2015)... 02, 2015 National Autism Resource has ... web design and development agency, to launch its new ... Autism Resources’ new website is designed to ... ages diagnosed with autism. The site will expand its ... array of resources, from easy to understand information and ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 With the ... in most parts of the United States, people will ... rooms. Despite the obvious benefits of air conditioning, a ... including dry eye, dehydration and allergic reactions. Fresh water ... Power of Water® radio show, will discuss the potential ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 PhishLine, ... Headquarters to 20800 Swenson Drive, Suite 125 in ... space provides a new base of operations for ... will accommodate future growth. , Mark Chapman, Founder ... in the industry as enterprise customers adopt our ...
(Date:6/2/2015)... Residents of Monarch Landing in Naperville are going ... class, do yoga, play volleyball, or participate in whatever ... Alzheimer’s Association’s Walk to End Alzheimer’s on September 20 ... a challenge to exercise for 60 days, sponsored by ... While the walk will raise awareness of Alzheimer’s disease ...
(Date:6/2/2015)... June 02, 2015 TranSlice: Reveal from Pixel ... style. TranSlice: Reveal allows Final Cut Pro X users to ... to reveal their next screen. , TranSlice Reveal brings back ... Final Cut Pro X users can now transition from ... , With every panel orientation and direction covered, no transition ...
Breaking Medicine News(10 mins):Health News:National Autism Resources Launches New Website, Delivering More Products and Services 2Health News:National Autism Resources Launches New Website, Delivering More Products and Services 3Health News:Air conditioning may contribute to dry eye, dehydration and allergies warns fresh water advocate Sharon Kleyne 2Health News:Air conditioning may contribute to dry eye, dehydration and allergies warns fresh water advocate Sharon Kleyne 3Health News:PhishLine, LLC Announces New Corporate Headquarters 2Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 2Health News:Monarch Landing Takes 60-Day Exercise Challenge to Combat Alzheimer’s 3Health News:Announcing the release of TranSlice Reveal from Pixel Film Studios - Professional Split Screen Transitions for FCPX. 2
... of an unfertilized egg or development of eggs from ... On! This is not all. Scientists have ... are made from a single egg, without the need ... parthenotes by taking donated eggs from women who were ...
... it is equally important to lose weight in a healthy ... whole grains and other such nutritious foods// seems tempting isn’t ... is more effective than the conventional diet regime. It is ... plant-based diet has been found to be more effective at ...
... a study by a researcher from University of California, ... are found not in the similarity of the genome ... them. ,Researcher had described genetic differences between the ... that is also expressed in brain cells associated with ...
... as over the counter drug with out medical prescription ... pregnancy. The decision was announced// by the Indian Health ... minister said, "The step has been taken to enable ... sexual exposure, contraceptive accident or forced sex," Dr. Suneeta ...
... the Steno Diabetes Center, Denmark has found that ... //antihypertensive drugs, reduced the chances of developing kidney ... in urine of these patients. ,Diabetes ... to kidney diseases. Supplementation of Spironolactone has found ...
... have died of it in the last three years. Unofficial estimates, ... more than 2,000 full-blown AIDS cases. The increase //in AIDS patients ... ,Jharkand plans to open condom booths in public places ... attempt to open the condom booths will help to educate people ...
Cached Medicine News:Health News:Weight loss accomplished by high carbohydrate, vegan diet 2Health News:Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug 2
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
... tubes contain a buffered sodium ... with a citrate concentration of ... mol/l (3.8%). The mixing ratio ... to 9 parts blood. In ...
... Cross-match tubes are available ... serum tube contains a clotting ... cross-match tests where serum is ... EDTA cross-match tube is suitable ...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: